The approaches to management of dyslipidemias are lifestyle intervention and lipid-modifying drug therapy. Reducing cardiovascular disease emphasize an overall healthy eating pattern and maintenance of appropriate body weight, together with achieving a desirable blood pressure and a desirable lipoprotein profile. Many people achieve healthy levels by eating a balanced diet and through other aspects of their lifestyle. However, some require medication to prevent additional health problems.Moreover, researchers are currently investigating the development of drugs directed at molecular targets, including cholesterol esterification and accumulation in macrophage foam cells. Risk equivalents that will encourage more aggressive therapeutic intervention for individuals at high short-term danger for dyslipidemias, even in the absence of clinically evident coronary disease.
Case Report: Cardiovascular Diseases & Diagnosis
Case Report: Cardiovascular Diseases & Diagnosis
Research Article: Cardiovascular Diseases & Diagnosis
Research Article: Cardiovascular Diseases & Diagnosis
Case Report: Cardiovascular Diseases & Diagnosis
Case Report: Cardiovascular Diseases & Diagnosis
Case Report: Cardiovascular Diseases & Diagnosis
Case Report: Cardiovascular Diseases & Diagnosis
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Alternative & Integrative Medicine
Posters & Accepted Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Nuclear Medicine & Radiation Therapy
Scientific Tracks Abstracts: Nuclear Medicine & Radiation Therapy
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report